Baylis Medical has taken the next pivotal step in its global expansion strategy with the official opening of a new state-of-the-art laboratory in Mississauga, Ontario.
| |
| [22-January-2018] |
| TORONTO, Jan. 22, 2018 /PRNewswire/ - Baylis Medical, a global medical device company, has taken the next pivotal step in its global expansion strategy with the official opening of a new state-of-the-art laboratory in Mississauga, Ontario. The new extrusion lab will allow the company to expand its capabilities and capacity to design, develop, manufacture and commercialize cutting-edge medical device technologies that will advance multiple fields of medical practice, including cardiology, radiology and spinal procedures. The announcement represents a significant step in Baylis Medical’s plan to rapidly develop innovative products by bringing more capabilities in-house. Previously, the extrusion of plastic tubes used in Baylis devices was done outside of Canada, resulting in higher costs and longer production cycles. “Bringing this capability in-house means we can shorten our development cycle, better control our production process and greatly improve our product design process,” says Kris Shah, President of Baylis Medical. “It shrinks our production time from about two months to less than 48 hours, which allows us to test even more design ideas, all while accelerating the production of both new and existing products.” Baylis Medical has hired additional technical staff to support this expansion. The company is also expanding its workforce to support the production of new product lines and reach new international markets. Baylis Medical was honoured to have several dignitaries attend the grand opening of its extrusion lab at 2775 Matheson Blvd. East, including the Honourable Reza Moridi, Ontario Minister of Innovation, Research and Science; Member of Provincial Parliament for Mississauga-Brampton South, Amrit Mangat; and Mayor of Mississauga, Bonnie Crombie. Baylis Medical’s expansion was supported by investments from the Government of Canada through the Federal Economic and Development Agency for Southern Ontario (FedDev Ontario)'s Advanced Manufacturing Fund and the Ontario government through the Jobs and Prosperity Fund. “Our Government is committed to helping Canadian companies fuel innovation, expand globally and create highly-skilled jobs that will ultimately strengthen our economy. Our investment in Baylis Medical is one way we are highlighting the skilled talent that is key to strengthening Canada’s global standing as a competitive and innovation nation,” says Navdeep Bains, Minister of Innovation, Science and Economic Development and Minister responsible for FedDev Ontario. “Baylis Medical is another great example of why Ontario is, and will remain, a leader in the innovation and knowledge economy. The Ontario government is proud to support homegrown successes that are creating jobs in Ontario and expanding sales abroad, particularly in the important field of medical devices which help improve the quality of lives for patients here in Ontario and around the world,” says Reza Moridi, Ontario’s Minister of Research, Innovation and Science. Shah says the company’s expanded capability reinforces its commitment to “put patients first” by developing innovative medical devices, prototyping and manufacturing in-house and selling and distributing globally. “Today’s grand opening signals a pivotal step in our company’s Vision 2020 plan, which includes building a healthy pipeline of new and innovative products and expanding our market globally,” says Shah. “It also strengthens our efforts to become a vertically integrated company with the in-house expertise needed to rapidly take an innovation from its raw material state to a manufactured device, including all the development and commercialization steps in between. We are now well-positioned to provide even more innovative and clinically relevant solutions that address real-world challenges.” About Baylis Medical Company Baylis Medical develops and markets high-technology medical devices used in the fields of interventional cardiology, interventional radiology, and spinal procedures. Our vision is to develop and market innovative medical therapies while improving the lives of people around the world. The company has offices in Montreal and Toronto (Canada), Boston (U.S.), London (U.K.) and Munich (Germany). For more information, visit www.baylismedical.com. PRM--00292 EN J-1,2,3 V-1 © Baylis Medical Company Inc., 2018. The Baylis Medical logo is a trademark or registered trademark of Baylis Medical Company Inc. in the United States and/or other countries. SOURCE Baylis Médical |
